oral cancer

New gene test detects early cancer risk

Researchers from Queen Mary, University of London have developed a new gene test that may detect precancerous cells in patients with oral lesions that appear

French firm brings candidiasis drug to U.S.

BioAlliance Pharma has signed a licensing agreement with Vestiq Pharmaceuticals to commercialize its Oravig product in the U.S. for the treatment of oropharyngeal candidiasis in

WhatsApp